RISK FACTORS FOR HYPERSENSITIVITY REACTIONS (HSRS) AMONG OVARIAN CANCER (EOC) PATIENTS TREATED WITH CARBOPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Jerzak, K. [1 ]
Manshadi, S. Deghan [1 ]
Ng, P. [2 ]
Maganti, M. [2 ]
McCuaig, J. M. [2 ]
Oza, A. [2 ]
Mackay, H. [2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0974
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [41] Carboplatin hypersensitivity induced by low-dose paclitaxel/carboplatin in multiple platinum-treated patients with recurrent ovarian cancer
    Watanabe, Y
    Nakai, H
    Ueda, H
    Nozaki, K
    Hoshiai, H
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (02) : 224 - 227
  • [42] Prophylactic effect of rikkunshito, an herbal medicine, for chemotherapy-induced nausea in thoracic cancer patients receiving carboplatin-based chemotherapy
    Hirose, C.
    Iihara, H.
    Funaguchi, N.
    Endo, J.
    Ito, F.
    Yanase, K.
    Kaito, D.
    Sasaki, Y.
    Gomyo, T.
    Sakai, C.
    Ohno, Y.
    Suzuki, A.
    PHARMAZIE, 2019, 74 (10): : 620 - 624
  • [43] Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy
    Kitazaki, Takeshi
    Fukuda, Yuichi
    Fukahori, Susumu
    Oyanagi, Kazuhiko
    Soda, Hiroshi
    Nakamura, Yoichi
    Kohno, Shigeru
    SUPPORTIVE CARE IN CANCER, 2015, 23 (01) : 185 - 190
  • [44] Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy
    Takeshi Kitazaki
    Yuichi Fukuda
    Susumu Fukahori
    Kazuhiko Oyanagi
    Hiroshi Soda
    Yoichi Nakamura
    Shigeru Kohno
    Supportive Care in Cancer, 2015, 23 : 185 - 190
  • [45] Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status
    Stinchcombe, TE
    Choi, J
    Schell, MJ
    Mears, A
    Jones, PE
    Nachtsheim, RV
    Socinski, MA
    LUNG CANCER, 2006, 51 (02) : 237 - 243
  • [46] Risk factors for recurrence of optimally staged/debulked ovarian or tubal cancer patients with adjuvant paclitaxel/carboplatin combination chemotherapy
    Kojimahara, T.
    Nakahara, K.
    Osakabe, M.
    Saitoh-Sekiguchi, M.
    Hayasaka, T.
    Motoyama, T.
    Kurachi, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Wertheim's hysterectomy after neoadjuvant carboplatin-based chemotherapy in patients with cervical cancer stage IIB and IIIB
    Meden, H
    Fattahi-Meibodi, A
    Osmers, R
    Krauss, T
    Kuhn, W
    ANTICANCER RESEARCH, 1998, 18 (6B) : 4575 - 4579
  • [48] Risk factors for febrile neutropenia in cancer patients treated with chemotherapy
    Family, Leila
    Li, Yanli
    Chen, Lie H.
    Page, John
    Klippel, Zandra Karina
    Chao, Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Carboplatin-based chemotherapy (CT) for advanced non small cell lung cancer (NSCLC) in eldery patients: A retrospective analysis
    Bencardino, K.
    Manzoni, M.
    Delfanti, S.
    Danova, M.
    Nascimbene, C.
    ANNALS OF ONCOLOGY, 2006, 17 : XI21 - XI21
  • [50] Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer
    Brault, Claudele
    Brind'Amour, Alexandre
    de Guerke, Lara
    Auclair, Marie-Helene
    Sideris, Lucas
    Dube, Pierre
    Soucisse, Mikael
    Tremblay, Jean-Francois
    Bernard, Laurence
    Piedimonte, Sabrina
    Fortin, Suzanne
    CURRENT ONCOLOGY, 2023, 30 (12) : 10272 - 10282
12345